Table 4.
RDW |
NLR |
PLR |
||||
---|---|---|---|---|---|---|
R | p | r | p | r | p | |
Disease duration (years) | 0.143 | 0.213 | 0.247 | 0.030 | 0.181 | 0.114 |
SLEDAI-2K | 0.288 | 0.012 | 0.111 | 0.343 | 0.183 | 0.116 |
SLICC/ACR | 0.235 | 0.039 | 0.017 | 0.881 | −0.072 | 0.531 |
C3 complement (mg/dl) | −0.165 | 0.153 | −0.249 | 0.019 | −0.324 | 0.004 |
C4 complement (mg/dl) | 0.055 | 0.637 | −0.150 | 0.194 | −0.140 | 0.224 |
ESR (mm/h) | 0.041 | 0.732 | 0.094 | 0.436 | 0.039 | 0.746 |
hsCRP (mg/l) | 0.258 | 0.026 | 0.094 | 0.426 | −0.154 | 0.190 |
Fibrinogen (mg/dl) | 0.255 | 0.025 | −0.022 | 0.852 | 0.051 | 0.659 |
Homocysteine (μmol/L) | 0.193 | 0.097 | 0.061 | 0.605 | 0.016 | 0.890 |
Ddimer (0.23 μg/ml) | 0.238 | 0.039 | 0.160 | 0.166 | 0.161 | 0.164 |
Creatinine (mg/dl) | 0.117 | 0.312 | −0.080 | 0.489 | −0.181 | 0.115 |
Creatinine clearance (Cockcroft) | −0.131 | 0.262 | 0.060 | 0.612 | −0.009 | 0.940 |
IL-6 (pg/ml) | 0.325 | 0.012 | 0.101 | 0.445 | 0.065 | 0.624 |
IL-10 (pg/ml) | 0.119 | 0.368 | 0.065 | 0.624 | −0.101 | 0.445 |
TNF (pg/ml) | 0.260 | 0.047 | 0.036 | 0.787 | 0.091 | 0.543 |
IFNγ (pg/ml) | 0.128 | 0.342 | 0.007 | 0.959 | 0.247 | 0.064 |
RDW: Red blood cell distribution width, NLR: Neutrophil-to-lymphocyte ratio, PLR: Platelet-to-lymphocyte ratio, SLEDAI: SLE Disease Activity Index, SLICC/ACR: Systemic Lupus International Collaborative Clinics/American College of Rheumatology, ESR: Erythrocyte sedimentation rate, hsCRP: High-sensitive C-reactive protein, TNF: Tumor necrosis factor, IFNγ: Interferon γ